Delivery Order SPE2DB22D2206-SPE2DB25FJW86
- Not listed
- The Defense Logistics Agency awarded a $1,346.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials. This contract, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-competitive set-aside delivery order executed through the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,645.74 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg tablets (500-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract is unclassified and has no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,576.30 in Mycophenolate 500 mg tablets (500-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.68 to AmerisourceBergen Drug Corp for Mycophenolate 200 mg/ml suspension in 160 ml quantities. The contract, awarded July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under a competitive procurement process, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical supply requirements. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,662.25 to AmerisourceBergen Drug Corp for the supply of Mycophenolate 200 mg/mL suspension in 160 mL quantities. The contract, awarded on July 29, 2025, with a completion date of July 30, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,219.46 delivery order to AmerisourceBergen Drug Corp for Mycophenolate 500 mg tablets (100 count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price, competitively awarded contract—which includes no set-aside designation—represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $4,296.65 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mycophenolate 200 mg/ml suspension in a 160 ml quantity, with completion targeted for July 28, 2025. This firm fixed price contract represents a non-competitive set-aside award to the pharmaceutical distributor's corporate office, with performance to be executed in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide MYCOPHENOLATE 500 MG TABLET 500S. The contract, valued at $1,388.16, has a completion date of February 23, 2024. AmerisourceBergen Drug Corp serves as the prime contractor for this order, which is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, to provide 160 ml bottles of Mycophenolate 200 mg/ml suspension. The $3,561.92 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order. No set-aside designation was used. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,028.61, is for the delivery of 4559144199 - Mycophenolate 500 mg vials. The contract has an ultimate completion date of November 21, 2022 and was awarded on November 18, 2022 as a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJW86Delivery Order
The Defense Logistics Agency awarded a $2,896.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mycophenolate 500 mg vials, with an ultimate completion date of September 12, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor supplying comprehensive pharmaceutical products and medical supplies to military and veteran healthcare systems. This delivery order for Mycophenolate, an immunosuppressive medication commonly used in transplant and autoimmune disease management, exemplifies the company's role within DLA's Medical Supply Chain. The underlying IDC vehicle enables AmerisourceBergen to fulfill diverse pharmaceutical requirements across multiple therapeutic domains globally, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible contracting mechanisms designed to ensure rapid availability of critical medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/11/25 |